Skip to Content
Merck
  • Bioprinting of Cartilage with Bioink Based on High-Concentration Collagen and Chondrocytes.

Bioprinting of Cartilage with Bioink Based on High-Concentration Collagen and Chondrocytes.

International journal of molecular sciences (2021-11-14)
Evgeny E Beketov, Elena V Isaeva, Nina D Yakovleva, Grigory A Demyashkin, Nadezhda V Arguchinskaya, Anastas A Kisel, Tatiana S Lagoda, Egor P Malakhov, Valentin I Kharlov, Egor O Osidak, Sergey P Domogatsky, Sergey A Ivanov, Petr V Shegay, Andrey D Kaprin
ABSTRACT

The study was aimed at the applicability of a bioink based on 4% collagen and chondrocytes for de novo cartilage formation. Extrusion-based bioprinting was used for the biofabrication. The printing parameters were tuned to obtain stable material flow. In vivo data proved the ability of the tested bioink to form a cartilage within five to six weeks after the subcutaneous scaffold implantation. Certain areas of cartilage formation were detected as early as in one week. The resulting cartilage tissue had a distinctive structure with groups of isogenic cells as well as a high content of glycosaminoglycans and type II collagen.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Collagen II antibody produced in rabbit, affinity isolated antibody